(active substance of AGOVIRAX) inhibits the cell entry of SARS-CoV-2
Iota - carrageenan
(active substance of AGOVIRAX) stops viral replication by inhibiting the attachment of viruses to cells
(active substance of AGOVIRAX) is a broad-spectrum clinically proven therapy against viral infections of the respiratory tract
Even if AGOVIRAX
cannot prevent completely an infection by SARS-CoV-2, it may strongly reduce the risk of an infection and virus spread
Indicated for prophylaxis and treatment of respiratory infections caused by viruses in adults and children from 1 year of age.
Therapeutic indications of Agovirax
Agovirax safety profile
Agovirax use and method of administration
Mode of action of Agovirax
Agovirax unique filter system
Signs and symptoms
Prophylaxis and cold management
What is a virus?
Respiratory syncytial virus (RSV)
Routes of transmission
Common cold prevention tips
Interesting facts about the common cold
GryNumber Health company info
Iota-carrageenan (active substance of Agovirax) inhibits the cell entry of SARS-CoV-2
The latest in vitro study confirmed, that “iota-carageenan inhibits the cell entry of SARS-CoV-2 (…), which suggests that administration of iota-carrageenan may be an effective and safe prophylaxis or treatment also for SARS-CoV-2 infections“. ¹
1. Morokutti-Kurz, Graf, Grassauer et al. SARS-CoV-2 in-vitro neutralization assay reveals inhibition of virus entry by iota-carrageenan. Pre-Peer review, July 2020.